Bitterman Robert J reported PHIO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001683168-26-007483

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 28, 2026

Published

Sep 29, 2026

Ingested by INSIDER

Nov 5, 02:14 UTC

Last re-read

Nov 5, 02:14 UTC

Extracted facts

Filer

Bitterman Robert J

Role

Director, Chairman, Pres. & CEO

Transaction

Grant or awardAs filed: “A”

Asset

Phio Pharmaceuticals Corp.

Ticker

PHIO

Shares

400.0K

Price per share

$0

Execution date (reported)

Sep 28, 2026

Owned after transaction

764.9K shares

Days from execution to publication

1

What this establishes

Bitterman Robert J filed this Form 4 reporting a grant or award of PHIO on Sep 28, 2026. It became public on Sep 29, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, Chairman, Pres. & CEO

Bitterman Robert Jcik:0001304395

Issuer

Phio Pharmaceuticals Corp.cik:0001533040

Revision history · 0

No field has changed since this record was first ingested.